MMP9 and neoplasm: Furthermore, the ability of CUR to inhibit MMP-9 and upregulate the tissue inhibitor of metalloproteinases-2 (TIMP-2) significantly suppresses tumor angiogenesis, metastasis, and cell proliferation, thereby complementing the antitumor mechanisms of PTX [16,17].